Related Experiment Video
Updated: May 24, 2025

Preparation of Large-area Vertical 2D Crystal Hetero-structures Through the Sulfurization of Transition Metal Films for Device Fabrication
Published on: November 28, 2017
Recent progress on transition metal dichalcogenide-based composites for cancer therapy
Bo Chen1, Yue Dai1, Suxiang Yang1
1State Key Laboratory of Flexible Electronics & Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced Materials (IAM), School of Chemistry and Life Sciences, Nanjing University of Posts and Telecommunications, Nanjing 210023, China. iambchen@njupt.edu.cn.
Abstract:
Cancer remains a global health challenge, driving the need for advanced treatments. While transition metal dichalcogenides (TMDs) show promise in cancer therapy, their stability and efficacy require improvement. This study explores TMD-based composites as a solution to enhance their therapeutic potential. This review begins by providing an overview of TMDs and emphasizing their preparation techniques and fundamental properties. The focus is then shifted to categorizing TMD-based composites based on their constituent materials, delving into various types, such as TMD-organic, TMD-carbon, TMD-metal chalcogenide, TMD-metal, and TMD-oxide composites, as well as more complex ternary and multinary systems. We further explore key fabrication strategies, including hydrothermal/solvothermal methods and surface deposition/coating techniques. Subsequently, the focus shifted to their applications in cancer treatment, including chemotherapy, photothermal therapy, phototherapy, and integrated combination therapies. Finally, critical challenges in the field and perspectives on potential directions for future research are presented.
More Related Videos
10:41Preparation of Liquid-exfoliated Transition Metal Dichalcogenide Nanosheets with Controlled Size and Thickness: A State of the Art Protocol
Published on: December 20, 2016
10:42Combining Solid-state and Solution-based Techniques: Synthesis and Reactivity of ChalcogenidoplumbatesII or IV
Published on: December 29, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...